Applied Therapeutics, Inc. (APLT) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-02-04

Applied Therapeutics, Inc. (APLT) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every APLT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Applied Therapeutics, Inc. (APLT)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001697532

Recent APLT Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-03	Kanter Stacy J.	Insider	J — Other acquisition / disposition	42.5K	—	—	SEC
2026-02-03	Chinoporos Constantine	See Remarks	D — Derivative transaction	1.00M	—	—	SEC
2026-02-03	Chinoporos Constantine	See Remarks	J — Other acquisition / disposition	57.1K	—	—	SEC
2026-02-03	SKYLER JAY S	Insider	D — Derivative transaction	22.5K	—	—	SEC
2026-02-03	SKYLER JAY S	Insider	J — Other acquisition / disposition	42.5K	—	—	SEC
2026-02-03	Funtleyder Leslie D.	Chief Financial Officer	D — Derivative transaction	2.38M	—	—	SEC
2026-02-03	Funtleyder Leslie D.	Chief Financial Officer	J — Other acquisition / disposition	153.0K	—	—	SEC
2026-02-03	Bailey Evan Prescott	Chief Medical Officer	D — Derivative transaction	1.24M	—	—	SEC
2026-02-03	Bailey Evan Prescott	Chief Medical Officer	J — Other acquisition / disposition	60.9K	—	—	SEC
2026-02-03	Lerner Teena	Insider	D — Derivative transaction	22.5K	—	—	SEC
2026-02-03	Lerner Teena	Insider	J — Other acquisition / disposition	82.9K	—	—	SEC
2026-02-03	Kanter Stacy J.	Insider	D — Derivative transaction	22.5K	—	—	SEC
2026-02-03	Hooks Corwin Dale	Chief Commercial Officer	D — Derivative transaction	862.5K	—	—	SEC
2026-02-03	Hooks Corwin Dale	Chief Commercial Officer	J — Other acquisition / disposition	5.8K	—	—	SEC
2026-01-01	Funtleyder Leslie D.	Chief Financial Officer	A — Grant or award	150.0K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Applied Therapeutics, Inc. (APLT). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2026-02-04 — Kanter Stacy J. (Insider)
2026-02-04 — Hooks Corwin Dale (Chief Commercial Officer)
2026-02-04 — Chinoporos Constantine (See Remarks)
2026-02-03 — SKYLER JAY S (Insider)
2026-02-03 — Funtleyder Leslie D. (Chief Financial Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in APLT insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

APLT Insider Trading — FAQ

What is the latest insider trade for APLT?: Applied Therapeutics, Inc. (APLT) had 0 insider filings in the last 90 days, with the most recent on 2026-02-04. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying APLT stock?: 0 insider purchases of APLT were filed in the last 90 days.
How many insiders are selling APLT stock?: 0 insider sales of APLT were filed in the last 90 days.
Where can I see APLT SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every APLT SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live APLT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.